password
username
Sponsored by CakeMail, an email marketing software
Newsletter preview

* THIS PROFESSIONAL NEWSLETTER IS NOT A SPAM.  IT IS SENT TO YOU BECAUSE EITHER YOU SUBSCRIBED IT YOURSELF OR SOMEONE SUBSCRIBED IT FOR YOU.  IF YOU BELIEVE YOU HAVE RECEIVED IT IN ERROR, PLEASE CONTACT US IMMEDIATELY (NEWSLETTER@PHARMCAST.COM AND WRITE "***" IN THE SUBJECT LINE).  YOUR PRIVACY IS VERY IMPORTANT TO US.  THANK YOU.

TO ***, PLEASE GO TO

http://www.pharmcast.com/Newsletter/***nl.htm
 

 

P H A R M C A S T  D O T  C O M
The www.PharmCast.com Official Newsletter

--------- December 23 - 07 ---------

 

+++ PharmCast.com's Patent/Technology Available for Licensing +++

Patent Available for Licensing:
“Polynucleotides for Inhibiting Metastasis and Tumor Cell Growth”
US Patent Number 6,268,350
Patent describes successful demonstration of the administration of FasL antisense and FasL sense polynucleotides in treatment of cancer patients with a solid, non-lymphoid tumor and/or its metastasis.

http://www.pharmcast.com/PatentToSubWeb/Licensing/AvailablePatents/BioCrystal/BioCrystal080807.htm
 

Do you have a patent/technology that you want to be listed on www.PharmCast.com?

http://www.pharmcast.com/PatentToSubWeb/Licensing/Licensing.htm. listing



 

+++ PharmCast.com's Conference Highlight +++
 

1.  Validation of Computer Systems, January 28-29, 2008, Malvern, PA.  Organized by The Center for Professional Innovation & Education.

http://www.cfpie.com/showitem.aspx?productid=081&source=pharmcast
 

2.  Ensuring Dosage Unit Uniformity - General Chapter <905> (Classroom/Online).  Organized by USP (United States Pharmacopeia).

http://www.usp.org/goto/phcdos
 

3.  Web Seminar: FDA Compliance for Network Infrastructure, January 23, 2008.  Speaker: Bernice Russell-Bond.  Organized by BenAstrum, Inc. (Use promotional code PC0108 for 10% discount)

http://www.benastrum.com/index.php?option=com_content&task=view&id=39&Itemid=69
 

4.  7th Successful, Compliant Investigator-Initiated Trials, February 21-22, 2008, Miami, FL.  Organized by ExL Pharma.

http://www.exlpharma.com/eventDetail.php?id=99
 

5.  Strategic Healthcare Resource Management, February 25-26, 2008, Bangkok Thailand.  Organized by Marcus Evans.

http://www.marcusevans.com/html/eventdetail.asp?eventID=13244&SectorID=27&divisionID=
 

6.  2nd Search Engine Marketing for Pharmaceuticals, February 25-26, 2008, Philadelphia, PA.  Organized by ExL Pharma.

http://www.exlpharma.com/eventDetail.php?id=97
 

7.  3rd Data Monitoring Committees Conference, February 25-26, 2008, Philadelphia, PA.  Organized by ExL Pharma.

http://www.exlpharma.com/eventDetail.php?id=100
 

8.  5th Lean Six Sigma For Pharmaceutical, Biotech and Medical Device Excellence, February 25-27, 2008, Philadelphia, PA.  Organized by IQPC.

http://www.iqpc.com/us/LSSP
 

9.  2nd Annual Conference on Recombinant Therapeutics, February 25-27, 2008, Berlin, Germany.  Organized by IQPC.

http://www.iqpc.com/de/recombinant/pharmcast
 




+++ PharmCast.com's Last Week Pharmaceutical Patents +++
 

http://www.pharmcast.com/PatentToSubWeb/Yr2007/Dec2007/Home120407OG.htm


1.  Method for preventing or treating the development of respiratory allergies

2.  Screening method for candidate drugs

3.  Method of treating eye injury with local administration of a VEGF inhibitor

4.  Preparation of aqueous clear solution dosage forms with bile acids

5.  Hookworm vaccine

6.  Cultures of GFAP nestin cells that differentiate to neurons

7.  Use of HMGB fragments as anti-inflammatory agents

8.  Biocompatible phase invertable proteinaceous compositions and methods for making and using the same

9.  Methods for the diagnosis and treatment of breast cancer

10.  Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases

11.  Stimulation of bone growth with thrombin peptide derivatives

12.  Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same

13.  Method for indirectly determining the blood-clotting status

14.  Therapeutic composition and method of supporting the immune system

15.  Absorption enhancers

16.  Antibodies binding to human TSLP Polypeptides

17.  Potent inhibition of influenza virus by specifically designed short interfering RNA

18.  Method for purifying pluri-differentiated mesenchymal progenitor cells

19.  .beta.-L-2'-deoxy-nucleosides for the treatment of hepatitis B

20.  Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin


 

+++ PharmCast.com's Last Week Federal Register +++
 

http://www.pharmcast.com/FederalRegistrar/FRHome.htm
 

December 21, 2007

1.  Final Rule: Viruses, Serums, Toxins, and Analogous Products; Standard Requirements for Live Vaccines

2.  Notice: National Toxicology Program (NTP); NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM); Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): Ten-Year Anniversary Symposium and Five-Year Plan

3.  Notice: Government-Owned Inventions; Availability for Licensing


December 19, 2007

1.  Notice: Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 019

2.  Final Rule: Over-the-Counter Vaginal Contraceptive and Spermicide Drug Products Containing Nonoxynol 9; Required Labeling (*Large Document, Linked Directly to Federal Register Website)

3.  Notice: Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

4.  Notice: A Business Plan To Advance Animal Disease Traceability

5.  Notice (A): Government-Owned Inventions; Availability for Licensing

6.  Notice (B): Government-Owned Inventions; Availability for Licensing


December 18, 2007

1.  Notice: In the Matter of: Avitech Life Sciences, Inc.; Order of Suspension of Trading


December 17, 2007

1.  Notice: International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex 3 on Test for Particulate Contamination: Subvisible Particles General Chapter; Availability

2.  Notice: International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 2 on Test for Extractable Volume of Parenteral Preparations General Chapter; Availability

3.  Notice: Guidance for Industry and Food and Drug Administration Review Staff: Collection of Platelets by Automated Methods; Availability




+++ PharmCast.com's Last Week Recent FDA Links +++


http://www.pharmcast.com/FDALinks/FDALinksLatest.htm
 

December 21, 2007

1. FDA updates the Public Health Advisory and Information for Healthcare Professionals sheet for fentanyl transdermal system (Duragesic and generics). MedWatch Safety Information (12/21/2007)

2.  Clinical Trial Design for Community-Acquired Pneumonia; Public Workshop, January 17-18, 2008, Silver Spring, Maryland. Meeting information (12/21/2007)

3.  BPCA/Pediatric Exclusivity Statistics: Written Requests Issued (updated 12/21/2007)

4.  Best Pharmaceuticals for Children Act of 2007: List of Determinations Including Written Request (updated 12/21/2007)


December 20, 2007

1.  Biological Product Shortages - Haemophilus influenza Type b (Hib) Conjugate (PedvaxHIB and Comvax) (Posted: 12/20/2007)

2.  Certification of Compliance, under 42 U.S.C. , 282(j)(5)(B), with Requirements of ClinicalTrials.gov Data Bank (42 U.S.C., 282(j)) - Form (Posted: 12/20/2007)


December 19, 2007

1.  WilBio 2nd Annual Cell Banking Meeting - 12/5/2007 (Posted 12/19/2007)
    a.  Regulatory Guidance on Using New Cell Substrates for Manufacture of Viral Vaccines (PDF - 250 KB) - Arifa S. Khan, PhD

2.  Drugs@FDA Downloadable Data Files (updated 12/19/2007)

3.  Office of Generic Drugs: November First-Time Generic Drug Approvals (updated 12/19/2007)

4.  Paragraph IV Patent Certifications (updated 12/19/2007)


December 18, 2007

1.  Adverse Drug Experience Reporting (updated 12/18/2007)

2.  User Fee Billable Products Approved Under Section 351 of the PHS Act - Update (Posted: 12/18/2007)

3.  Workshop: Immune Correlates of Protection Against Influenza A Viruses in Support of Pandemic Vaccine Development - Webcast (Posted: 12/18/2007)

 

_____________________________________________________________

PharmCast Dot Com, the Official www.PharmCast.com's Newsletter.

Copyright GF Communications
To ***, please go to:

http://www.pharmcast.com/Newsletter/***nl.htm

  

 

patents * jobs * Federal Register * news * stocks * FDA Links * Buyer's Guide

 

 

 

 


This email was sent to ralrusu@gmail.com, by newsletter@pharmcast.com

GF Communications | www.PharmCast.com | Clearwater | FL | 33762